Antidiabetic activity and safety evaluation of two Cameroonian medicinal plants in Streptozotocin-rat model: Tetrapleura tetraptera (Fabaceae) and Irvingiagabonensis (Irvingiaceae)
Abstract
Background: Irvingia gabonensis and Tetrapleura tetraptera are widely employed by traditional healers of the southern regions of Cameroon to treat diabetes. However. there is only limited or no scientific evidence on the real potential of these two medicinal plants to serve as alternative therapies. The present works thus aimed to evaluate the antidiabetic activity of the barks of I. gabonensis and fruits of T. tetraptera. Methods: The antidiabetic potential of the four extracts was assessed by evaluating the hypoglycaemic activity through the oral glucose tolerance test (OGTT) in male Wistar albino rats and the subacute antidiabetic assay in streptozotocin-induced Wistar rat model. For the later. clinical markers (water and food intake, urine excretion), Fasting Blood Sugar FBS), the effects on some vital organs (liver and kidney), and lipid profile were considered. Safety was evaluated using the in vivo acute toxicity test in mouse model. Results: Out of the four extracts prepared from T. tetraptera and I. gabonensis, and tested for their antidiabetic potential, only the hydroethanol extract of the stem bark of I. gabonensis showed promising hypoglycemic and anti-hyperglycemic activity from preliminary screening. Of the two doses of this extract considered for the subacute antidiabetic assessment, the dose of 500mg/Kg demonstrated the highest activity reflected in significant improvement in both clinical and biochemical markers with a 100% recovery rate after 21 days treatment of the STZ-induced diabetic Wistar rats. At this dose, the I. gabonensis extract was shown to also improve liver and kidney functions as well as mitigating dyslipidemia in diabetic rats. Overall, its pharmacological properties were above those of the reference drug metformin at 10mg/Kg dose. More interestingly, the acute toxicity study revealed a relative safety of this extract in mice. Conclusion: The present work confirms the potential of the hydroethanolic extract of I. gabonensis to serve a source of new antidiabetic drugs. Further investigations are therefore envisaged.
Downloads
References
2. Ngassam E., Nguewa J-L., Ongnessek S., Foutko A., Mendane F, Balla V., Limen S., Orr-Walker B., Sobngwi S., Mbanya J-C. (2012). Cout de la prise en charge du diabète de type 2 à l’hopital central de yaounde. Diabetesmetabolism. 38(2) : 32-111.
3. Gregg E., Li Y., Wang J., Burrows N., Ali M., Rolka D. (2014). Changes in diabetes-related complications in the United States, 1990–2010.England Journal of Medicine. 370(16): 15-23.
4. Teugwa M., Mejiato C., Zofou D., Tchinda T., Boyom M. (2013). Antioxidant and antidiabetic profiles of two African medicinal plants: Picralima nitida (Apocynaceae) and Sonchus oleraceus (Asteraceae). BMC Complementary and Alternative Medicine. 13: 175-200.
5. Nole T., Tsambang L., Tsambang C., Agbor G. (2016). Ethnomedical and Ethnopharmacological Study of Plants Used for Potential Treatments of Diabetes and Arterial Hypertension by Indigenous People in Three Phytogeographic Regions of Cameroon. Diabetes Case Reports. 1: 6-9.
6. Dibong S., Loe E., Ngoule C., Mbome B., Pouka K., Ngene J., Yinyang J., Ebongue O., Ngaba G. (2018). Contribution à l’étude des plantes médicinales et leurs utilisations traditionnelles dans le département du Lom et Djerem (Est, Cameroun). Journal of Animal and Plant Sciences. 35(1) : 5560-5578.
7. Teugwa M., Mejiato C., Zofou D., Tchinda T., Boyom M. (2013). Antioxidant and antidiabetic profiles of two African medicinal plants: Picralima nitida (Apocynaceae) and Sonchus oleraceus (Asteraceae). BMC Complementary and Alternative Medicine. 13: 175-200.
8. Akhere A. Omonkhua, Iyere O. Onoagbe.Long-term effects of three hypoglycaemic plants (Irvingia gabonensis, Urena lobata and Carica papaya) on the oxidative status of normal rabbits.
9. Aliyu Nuhu, Ezzeldin M. Abdurahman, Umar H. Danmalam, Muhammed U. Kawu, Ali M. Zakariya, Ayodeji E. Ayeni. Safety profile of Irvingia gabonensis (Aubry-Lecomte ex O’Rorke) Baill. root bark extract: Acute and sub-acute toxicity studies in Wistar rats.Journal of Medicinal Plants for Economic Development | Vol 4, No 1 | a102 | DOI: https://doi.org/10.4102/jomped.v4i1.102
10. Atanu FO, Ikeojukwu A, Owolabi PA, Avwioroko OJ. Evaluation of chemical composition, in vitro antioxidant, and antidiabetic activities of solvent extracts of Irvingia gabonensis leaves. Heliyon. 2022 Jul 9;8(7):e09922. doi: 10.1016/j.heliyon.2022.e09922. PMID: 35847614; PMCID: PMC9283886.
11. Catherine Otitolaiye, Akhere Omonkhua, Kelly Oriakhi, Edward Okello, Iyere Onoagbe, Friday Okonofua. Phytochemical Analysis and in vitro Antioxidant Potential of Aqueous and Ethanol Extracts of Irvingia gabonensis Stem Bark. Pharmacogn. Res., 2023; 15(2):363-372.
12. Chinedu O. Okolo, Patricia B. Johnson, Ezzel M. Abdurahman, Ibrahim Abdu-Aguye, Isa M. Hussain. Analgesic effect of Irvingia gabonensis stem bark extract. Journal of Ethnopharmacology 45(2), February 1995, Pages 125-129. https://doi.org/10.1016/0378-8741(94)01199-A.
13. Ezeasor, C.K., Chukwuma, C., Ekere, S.O. et al. Subchronic toxicity studies of aqueous leaf and stem bark extract of Irvingia gabonensis in male albino wistar rats. Comp Clin Pathol 26, 553–559 (2017). https://doi.org/10.1007/s00580-017-2417-3.
14. International Diabetes Federation - IDF (2019). Diabetes Atlas, 9TH edition 2019. Online version of IDF Diabetes Atlas :www.diabetesatlas.org ISBN: 978-2-930229-87-4, visité le 18 Novembre 2021.
15. Judith Laure Ngondi , Emile Joachim Djiotsa, Zephyrin Fossouo, Julius Oben. Hypoglycaemic Effect Of The Methanol Extract of Irvingia gabonensis Seeds on Streptozotocin Diabetic Rats. African Journal TraditionalComplementary and AlternativeMedicine (2006) 3 (4): 74 – 77.
16. Ngondi J., Fossouo Z., Djiotsa J., Oben J. (2006). Glycaemic variations after administration of Irvingiagabonensis seed fractions in normoglycaemic rats. African Journal of Traditional, Complementary and Alternative Medicines. 4: 94-100.
17. Odebiyi O, Sofowora EA: Phytochemical screening: Nigeria Medicinal plants. Loydia 1978, 41:234–235.
18. Ojewole JA, Adewunmi CO. Anti-inflammatory and hypoglycaemic effects of Tetrapleura tetraptera (Taub) [Fabaceae] fruit aqueous extract in rats. J Ethnopharmacol. 2004 Dec;95(2-3):177-82. doi: 10.1016/j.jep.2004.06.026. PMID: 15507333.
19. Onoagbe, I., & Omonkhua, A.A. (2013). Anti-diabetic, anti-hyperlipidaemic and anti-oxidant effects of total saponin fractions of Irvingia gabonensis stem bark on streptozotocin diabetic female rats. Planta Medica, 79.
20. Otitolaiye C, Omonkhua A, Oriakhi K, Okello E, Onoagbe I, Okonofua F. Phytochemical Analysis and In vitro Antioxidant Potential of Aqueous and Ethanol Extracts of Irvingia gabonensis Stem Bark. Pharmacog Res. 2023;15(2):363-72.
21. Sun J, Chen P. Ultra-high-performance liquid chromatography with high-resolution mass spectrometry analysis of African mango (Irvingiagabonensis) seeds, extract, and related dietary supplements. J Agric Food Chem. 2012 Sep 5;60(35):8703-9. doi: 10.1021/jf302703u.
22. Victor KueteandThomasEfferth. Cameroonian medicinal plants: pharmacology and derived natural products. Frontiers in Pharmacology | Ethnopharmacology; October 2010 Vol.1, Article 123. doi: 10.3389/fphar.2010.00123.
23. Yoon, S.-Y.; Kim, J.; Lee, B.S.; Baek, S.C.; Chung, S.J.; Kim, K.H. Terminalin from African Mango (Irvingia gabonensis) Stimulates Glucose Uptake through Inhibition of Protein Tyrosine Phosphatases. Biomolecules 2022, 12, 321. https://doi.org/10.3390/biom12020321
24. Zofou D, Manfo FPT, Mofor CT, Lum P, Nebangwa DN, Assob JCN. Antidiabetic and safety evaluation of Afya tea® (Aqueousextract of Moringa oleifera Lam.) in streptozotocin-rat model. Int J Ind Herbs Drugs 2017; 2(5): 1-10
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
.